Pulmonary hypertension
To view the entire topic, please log in or purchase a subscription.
Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:
-- The first section of this topic is shown below --
Etiology
- Primary pulmonary hypertension
- Chronic pulmonary embolism
- Chronic obstructive pulmonary disease (COPD)
- Interstitial lung disease
- Sleep apnea
- Pickwickian syndrome (obesity-hypoventilation syndrome)
- Scleroderma or other connective tissue disease
- Left to right intracardiac shunt
- Drugs or toxins: fenfluramine, dexfenfluramine, phentermine, bleomycin, amiodarone, talc (via IV drug use)
- Radiation
- Pulmonary veno-occlusive disease
- Valve disease: mitral stenosis, mitral regurgitation, aortic stenosis
- Left-sided heart failure
- Atrial myxoma
- High altitude (chronic mountain sickness)
- Polycythemia vera
- Cirrhosis with portal hypertension
- HIV
- Schistosomiasis
- Sickle cell disease
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Etiology
- Primary pulmonary hypertension
- Chronic pulmonary embolism
- Chronic obstructive pulmonary disease (COPD)
- Interstitial lung disease
- Sleep apnea
- Pickwickian syndrome (obesity-hypoventilation syndrome)
- Scleroderma or other connective tissue disease
- Left to right intracardiac shunt
- Drugs or toxins: fenfluramine, dexfenfluramine, phentermine, bleomycin, amiodarone, talc (via IV drug use)
- Radiation
- Pulmonary veno-occlusive disease
- Valve disease: mitral stenosis, mitral regurgitation, aortic stenosis
- Left-sided heart failure
- Atrial myxoma
- High altitude (chronic mountain sickness)
- Polycythemia vera
- Cirrhosis with portal hypertension
- HIV
- Schistosomiasis
- Sickle cell disease
There's more to see -- the rest of this topic is available only to subscribers.